CRISPR Screening Identifies Mechanisms of Resistance to KRASG12C and SHP2 Inhibitor Combinations in Non-Small Cell Lung Cancer.
作者:
主题词
人类(Humans);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);肺肿瘤(Lung Neoplasms);磷酸肌醇3-激酶类(Phosphatidylinositol 3-Kinases);原癌基因蛋白质类p21(ras)(Proto-Oncogene Proteins p21(ras));蛋白激酶抑制剂(Protein Kinase Inhibitors);癌症早期检测(Early Detection of Cancer);酶抑制剂(Enzyme Inhibitors);突变(Mutation);细胞系, 肿瘤(Cell Line, Tumor)
DOI
10.1158/0008-5472.CAN-23-1127
PMID
37934115
发布时间
2024-02-09
- 浏览0

Cancer research
4130-4141页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文